en
Scientific article
English

Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease

Published inDrug development and industrial pharmacy, vol. 37, no. 9, p. 1100-1109
Publication date2011
Abstract

In recent years, many achievements have been realized in the therapy of inflammatory bowel disease (IBD) although its etiology remains unknown. Thus IBD treatment is symptomatic and targets general inflammatory mechanisms. Oral formulations containing 5-aminosalicylic acid (5-ASA) have become the standard therapy for mild-to-moderate IBD.

Keywords
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal/administration & dosage
  • Clinical Trials as Topic
  • Drug Compounding/methods
  • Drug Delivery Systems/methods
  • Humans
  • Inflammatory Bowel Diseases/drug therapy/physiopathology
  • Mesalamine/administration & dosage
Affiliation Not a UNIGE publication
Citation (ISO format)
BAUTZOVA, Tereza, RABIŠKOVÁ, Miloslava, LAMPRECHT, Alf. Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease. In: Drug development and industrial pharmacy, 2011, vol. 37, n° 9, p. 1100–1109. doi: 10.3109/03639045.2011.560156
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0363-9045
813views
0downloads

Technical informations

Creation05/23/2017 3:26:00 PM
First validation05/23/2017 3:26:00 PM
Update time03/15/2023 1:43:20 AM
Status update03/15/2023 1:43:20 AM
Last indexation01/17/2024 12:01:26 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack